<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This case report describes the use of Rituximab for in vivo purging (by intravenous infusion) in a 12 years old boy with second remission of <z:e sem="disease" ids="C1292769" disease_type="Neoplastic Process" abbrv="">pre-B ALL</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>It was followed by conditioning therapy consisted of Busulphan and <z:chebi fb="0" ids="4027">Cyclophosphamide</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>rh-G-CSF primed stem cells from an HLA identical sibling donor were infused </plain></SENT>
<SENT sid="3" pm="."><plain>Standard <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft versus host disease</z:e> prophylaxis was given </plain></SENT>
<SENT sid="4" pm="."><plain>He engrafted within two weeks </plain></SENT>
<SENT sid="5" pm="."><plain>He did not develop <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft versus host disease</z:e> (aGvHD) but localized <z:hpo ids='HP_0011010'>chronic</z:hpo> GvHD developed </plain></SENT>
<SENT sid="6" pm="."><plain>He had been on regular follow-up at CMH, Rawalpindi and is in complete remission 13 months post-PBSCT with no evidence of <z:hpo ids='HP_0011010'>chronic</z:hpo> GvHD at present </plain></SENT>
</text></document>